Retour
DAFALGAN Direct gran 500 mg pamplemousse (nc 04/22)
UPSA Switzerland AG
| Article | Pénurie | Pharmacode | Prix | Cat. de remise | Cat. de remboursement |
|---|
Articles de substitution sans pénurie d'approvisionnement signalée
| Article | Pénurie | Pharmacode | Prix | Cat. de remise | Cat. de remboursement | Relation médicamenteuse | |
|---|---|---|---|---|---|---|---|
DAFALGAN Direct gran 500 mg baies rouges 16 pceUPSA Switzerland AG | 7834178 | Cat. D | Équivalent | ||||
DAFALGAN cpr eff 500 mg 40 pceUPSA Switzerland AG | 1035771 | Cat. B | SL / 10% | Dosage | |||
DAFALGAN cpr eff 500 mg 16 pceUPSA Switzerland AG | 1336653 | Cat. B | SL / 10% | Dosage | |||
DAFALGAN Dolo cpr eff 500 mg 16 pceUPSA Switzerland AG | 1113995 | Cat. D | Dosage | ||||
DAFALGAN cpr eff 1 g 20 pceUPSA Switzerland AG | 2181276 | Cat. B | SL / 10% | Forme | |||
DAFALGAN Direct gran 250 mg fraise sach 16 pceUPSA Switzerland AG | 7834179 | Cat. D | Forme | ||||
DAFALGAN Direct gran 1000 mg baies rouges 16 pceUPSA Switzerland AG | 1119260 | Cat. B | Forme | ||||
DAFALGAN Direct cpr orodisp 500 mg bte 16 pceUPSA Switzerland AG | 1036205 | Cat. D | Forme | ||||
ACETALGINE supp 500 mg 10 pceStreuli Pharma AG | 1379680 | Cat. D | SL / 10% | Substance | |||
ACETALGINE cpr 500 mg 100 pceStreuli Pharma AG | 915053 | Cat. B | SL / 10% | Substance |